Furthermore, we demonstrated that in vivo transfer of purified AAMФs (F4/80+MR+) recruited for this infection is able to modulate ongoing colitis; thus, it is possible that these cells not only prevent the development of colitis but also may play a curative role. This evidence concerns the gene NR3C2 and infection.